Metacrine is a synthetic derivative of the natural product emetine, an alkaloid originally isolated from the ipecacuanha plant. It is a potent and selective inhibitor of dihydroorotate dehydrogenase (DHODH), a key enzyme in the de novo pyrimidine biosynthesis pathway. This compound is characterized by its complex isoquinoline alkaloid structure. The primary and most significant application of Metacrine is in oncology research and development as a potential therapeutic agent for acute myeloid leukemia (AML). By inhibiting DHODH, it disrupts the production of nucleotides essential for rapidly proliferating cancer cells, leading to cell cycle arrest and apoptosis. Its selectivity and mechanism of action have made it a valuable tool compound for studying pyrimidine metabolism in cancer biology and a candidate for further drug development. Beyond its direct role as an investigational API, Metacrine serves as a key reference standard and a structurally interesting scaffold in medicinal chemistry. Its origin from a natural product template places it within the realm of bioactive natural product derivatives studied for their pharmacological potential.